These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8536780)

  • 1. Opiate antagonists in erectile dysfunction: a possible new treatment option? Results of a pilot study with naltrexone.
    van Ahlen H; Piechota HJ; Kias HJ; Brennemann W; Klingmüller D
    Eur Urol; 1995; 28(3):246-50. PubMed ID: 8536780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic erectile dysfunction in men with the opiate antagonist naltrexone--a double-blind study.
    Brennemann W; Stitz B; Van Ahlen H; Brensing KA; Klingmüller D
    J Androl; 1993; 14(6):407-10. PubMed ID: 8294223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients.
    Guardia J; Roncero C; Galan J; Gonzalvo B; Burguete T; Casas M
    Addict Behav; 2011 Mar; 36(3):265-9. PubMed ID: 21146937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence.
    Farren CK; O'Malley S
    Am J Addict; 2002; 11(3):228-34. PubMed ID: 12202015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
    Grant JE; Kim SW; Odlaug BL
    Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].
    Krupitsky EM; Blokhina EA; Zvartau EE; Verbitskaya VE; Bushara EM; Tiurina AA; Palatkin VY; Yaroslavtseva TS; Burakov AM; Masalov DV; Romanova TN; Grininko AY; Sinha R; Kosten T
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):39-46. PubMed ID: 26525620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone effects on short-term and long-term smoking cessation.
    Covey LS; Glassman AH; Stetner F
    J Addict Dis; 1999; 18(1):31-40. PubMed ID: 10234561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study.
    Grant JE; Odlaug BL; Schreiber LR; Kim SW
    J Clin Psychopharmacol; 2014 Feb; 34(1):134-8. PubMed ID: 24145220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
    Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
    Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
    Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
    Foster J; Brewer C; Steele T
    Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of pruritus with naltrexone, an orally active opiate antagonist.
    Metze D; Reimann S; Luger TA
    Ann N Y Acad Sci; 1999 Oct; 885():430-2. PubMed ID: 10816681
    [No Abstract]   [Full Text] [Related]  

  • 14. Naltrexone-induced augmentation of sexual response in men.
    Sathe RS; Komisaruk BR; Ladas AK; Godbole SV
    Arch Med Res; 2001; 32(3):221-6. PubMed ID: 11395188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory vulvovaginal pruritus with naltrexone, a specific opiate antagonist.
    Böttcher B; Wildt L
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():115-6. PubMed ID: 24388844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endorphins in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy.
    Fabbri A; Jannini EA; Gnessi L; Moretti C; Ulisse S; Franzese A; Lazzari R; Fraioli F; Frajese G; Isidori A
    Psychoneuroendocrinology; 1989; 14(1-2):103-11. PubMed ID: 2543996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study.
    Kongkanand A; Ratana-Olarn K; Ruangdilokrat S; Tantiwong A;
    J Med Assoc Thai; 2003 Mar; 86(3):195-205. PubMed ID: 12757058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence.
    Mason BJ; Ritvo EC; Morgan RO; Salvato FR; Goldberg G; Welch B; Mantero-Atienza E
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1162-7. PubMed ID: 7847600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.